1. Home
  2. ERAS vs CWBC Comparison

ERAS vs CWBC Comparison

Compare ERAS & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERAS
  • CWBC
  • Stock Information
  • Founded
  • ERAS 2018
  • CWBC 1989
  • Country
  • ERAS United States
  • CWBC United States
  • Employees
  • ERAS 129
  • CWBC N/A
  • Industry
  • ERAS Biotechnology: Pharmaceutical Preparations
  • CWBC Major Banks
  • Sector
  • ERAS Health Care
  • CWBC Finance
  • Exchange
  • ERAS Nasdaq
  • CWBC Nasdaq
  • Market Cap
  • ERAS 413.6M
  • CWBC 399.1M
  • IPO Year
  • ERAS 2021
  • CWBC 1996
  • Fundamental
  • Price
  • ERAS $1.42
  • CWBC $20.16
  • Analyst Decision
  • ERAS Strong Buy
  • CWBC Buy
  • Analyst Count
  • ERAS 6
  • CWBC 3
  • Target Price
  • ERAS $4.83
  • CWBC $20.67
  • AVG Volume (30 Days)
  • ERAS 1.1M
  • CWBC 90.3K
  • Earning Date
  • ERAS 08-11-2025
  • CWBC 07-29-2025
  • Dividend Yield
  • ERAS N/A
  • CWBC 2.30%
  • EPS Growth
  • ERAS N/A
  • CWBC N/A
  • EPS
  • ERAS N/A
  • CWBC 0.65
  • Revenue
  • ERAS N/A
  • CWBC $120,399,000.00
  • Revenue This Year
  • ERAS N/A
  • CWBC $32.95
  • Revenue Next Year
  • ERAS N/A
  • CWBC $6.55
  • P/E Ratio
  • ERAS N/A
  • CWBC $32.13
  • Revenue Growth
  • ERAS N/A
  • CWBC 38.79
  • 52 Week Low
  • ERAS $1.01
  • CWBC $15.57
  • 52 Week High
  • ERAS $3.45
  • CWBC $22.89
  • Technical
  • Relative Strength Index (RSI)
  • ERAS 53.15
  • CWBC 56.94
  • Support Level
  • ERAS $1.42
  • CWBC $20.82
  • Resistance Level
  • ERAS $1.58
  • CWBC $21.37
  • Average True Range (ATR)
  • ERAS 0.10
  • CWBC 0.45
  • MACD
  • ERAS 0.01
  • CWBC 0.01
  • Stochastic Oscillator
  • ERAS 68.65
  • CWBC 51.01

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.

Share on Social Networks: